Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN04
- Pharmacological subgroupN04B
- Chemical subgroupN04BC
- Chemical substanceN04BC04Ropinirole
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 45 medicines
HALMED · 12 medicines
MS · 12 medicines · Historical list
AIFA · 9 medicines
ALIMS · 9 medicines
SFDA · 7 medicines · Historical list
HSA · 5 medicines
PHARMAC · 4 medicines
FDA · 4 medicines
Anvisa · 1 medicine · Historical list
EMA · 1 medicine · Historical list
Show all 1Every register, a page at a time. Strengths and packs are on each medicine’s page.
4 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ropinirole Hydrochloride | United States | 12MG BASE, 2MG BASE, 3MG BASE … | tablet, extended release | Marketed | Chartwell RX |
| Ropinirole Hydrochloride | United States | 0.25MG BASE, 0.5MG BASE, 1MG BASE … | tablet | Marketed | Cosette |
| Requip | United States | 0.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | tablet | Not marketed | Glaxosmithkline LLC |
| Requip XL | United States | 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | tablet, extended release | Not marketed | Glaxosmithkline LLC |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.